Hurricane-related IV fluid shortage could hurt medical device makers
Corrects dateline to Oct 17
By Manas Mishra and Christy Santhosh
Oct 17 (Reuters) -A shortage of intravenous (IV) saline fluids due to Hurricane Helene is forcing hospitals to defer non-urgent surgeries, and could hurt companies that make medical devices for elective procedures if the supply crunch persists, analysts said.
Baxter International's BAX.N North Carolina plant, which makes 60% of the nation's supply of IV fluids and some key dialysis solutions, was closed for production late last month due to hurricane-related flooding.
Since then, hospitals have postponed elective surgeries even as the U.S. government, Baxter and other suppliers have rushed to bring in supplies from other facilities, including from overseas. Baxter has said it expects to meet 90% of customer needs by year end.
The big question for medical device makers is how soon the shortage can be resolved, said Barclays analyst Matt Miksic in an interview.
If resolved soon, "whatever gets pushed out of this quarter will likely get picked up the following quarter in terms of delayed surgeries," said Miksic. "We wouldn't expect at this point (a) significant.. sustaining impact on the stocks."
J&J became the first medical device company to flag a potential hit on Tuesday, when it warned that the IV saline shortages could impact surgical procedures across its portfolio if they persist.
During a surgery, patients are administered a normal saline solution or a type of IV fluid called Lactated Ringer's to replenish lost fluids.
Germany's Fresenius and medtech company B. Braun Medical said last week they were ramping up production of IV fluids to mitigate the shortage.
Device makers including Boston Scientific BSX.N, Edwards Lifesciences EW.N, Medtronic MDT.N and Stryker SYK.N, and hospital operators such as HCA Healthcare HCA.N and Tenet Healthcare THC.N are likely to face questions about the potential impact from the shortage when they report earnings in the coming weeks.
Baxter is expected to report its quarterly earnings on Nov. 8.
Given that the shortage is not expected to last too long, the impact on hospital operators and other providers should be modest in the fourth quarter, Jefferies analyst Brian Tanquilut said in a Wednesday research note.
Morningstar analyst Julie Utterback said the recent storms could be a "short-term concern" for HCA, and do not typically change the long-term outlook for such hospital operators.
Reporting by Manas Mishra and Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
